Thorkild Norregaard, MD
Neurological Surgery · Columbia, MONPI 1699805291
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (34.6%), travel and lodging and royalties or licence payments — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Ulrich Medical USA, Inc. at 57.6% of the total. Reporting peaked in 2019 at $10,986 and has fallen 53.0% since, to $5,169 in 2025.
Across 91 payments — averaging $317.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ulrich Medical USA, Inc.$17K
- Spinesource, Inc.$5K
- GS Solutions, Inc.$2K
- Globus Medical$2K
- Degen Medical, Inc.$1K
- Abbott$1K
- plus $1K from 4 others
Across 3 payments — averaging $6750.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GS Solutions, Inc.$20K
What the payments were for
- Royalty or licence$5,16918%
- Consulting fees$5,00017%
- Speaking & faculty fees$10,00035%
- Travel & lodging$5,70520%
- Food & beverage$3,05811%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ulrich Medical USA, Inc. | 5 | $16,669 |
| Spinesource, Inc. | 2 | $5,128 |
| GS Solutions, Inc. | 4 | $1,865 |
| Globus Medical | 6 | $1,773 |
| Degen Medical, Inc. | 2 | $1,254 |
| Abbott | 55 | $1,068 |
| Medtronic(2 entities) | 11 | $690 |
| Boston Scientific | 4 | $306 |
| Cerapedics Inc. | 1 | $156 |
| Johnson & Johnson | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- L-Varlock$5,128
- ExcelsiusGPS Robotic Navigation System$1,741
- Pipeline$182
- I-FACTOR PEPTIDE ENHANCED BONE GRAFT$156
- INTELLIS$141
- PROCLAIM$135
- Proclaim Family of SCS IPGs$128
- RESTORE$125
- VERCISE$110
How this compares
$28,931 in reported general payments places this provider in the 85th percentile of 172 neurological surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 20 | $366 |
| Mupirocin | 22 | $139 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 26 | $105 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Columbia
- Carolyn QuinseyColumbia$22K
- Fassil MesfinColumbia$15K
- Farhan SiddiqColumbia$14K
- Bornali KunduColumbia$8K
- Neill WrightSaint Louis$1.1M
- Wilson RaySaint Louis$586K
- Carlos BagleyKansas City$532K
- Kaywan GamadiaCape Girardeau$458K
- Camilo MolinaSaint Louis$412K
- Paul SantiagoSaint Louis$368K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.